US BANCORP \DE\ - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,0000.0%5000.0%0.00%
Q4 2021$1,0000.0%5000.0%0.00%
Q3 2021$1,000
-50.0%
5000.0%0.00%
Q2 2021$2,0005000.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Values First Advisors, Inc. 49,111$517,0000.48%
Aristides Capital LLC 31,300$330,0000.23%
ARK Investment Management 1,743,618$18,360,0000.11%
SABBY MANAGEMENT, LLC 59,730$629,0000.09%
MEITAV INVESTMENT HOUSE LTD 152,438$1,605,0000.08%
Shepherd Financial Partners LLC 22,070$232,0000.06%
Savior LLC 3,393$36,0000.04%
ETF MANAGERS GROUP, LLC 57,586$554,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 52,300$551,0000.02%
Focused Wealth Management, Inc 6,000$63,0000.01%
View complete list of PLURISTEM THERAPEUTICS INC shareholders